Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3653836 A
Publication typeGrant
Publication dateApr 4, 1972
Filing dateAug 26, 1970
Priority dateAug 27, 1969
Also published asDE1943580A1, DE1943580B2
Publication numberUS 3653836 A, US 3653836A, US-A-3653836, US3653836 A, US3653836A
InventorsBernt Erich, Dollacker Werner, Gruher Wolfgang, Wahlefeld August Wilhelm
Original AssigneeWahlefeld August Wilhelm, Bernt Erich, Dollacker Werner, Gruher Wolfgang
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Reagent for determining blood sugar
US 3653836 A
Abstract
A color-producing reagent for determining blood sugar comprising o-toluidine, thiourea, an ethylene glycol mono-lower alkyl ether, phthalic acid, and dimethyl formamide as a solubilizing agent, is outstandingly sensitive even to very low blood sugar contents, as in hypoglycaemia, and exhibits prolonged color stability.
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent Gruber et al.

[451 Apr. 4, 1972 REAGENT FOR DETERMINING BLOOD SUGAR Inventors: Wolfgang Gruher, Garatshausen nr. 16; Erich Bernt, 8000 Munich, Grunwalder Strasse 34; August Wilhelm Wahlefeld, Weilheim, Andreus-Schmidtner Strasse 20; Werner Doilacker, 8000 Munich, Schopenhege t 1.?" 9f Filed: Aug. 26, 1970 Appl. No.: 66,953

[30] Foreign Application Priority Data Aug. 27, 1969 Germany "P 19 43 580.4

US. Cl... ..23/230 B, 252/408 1m. Ci ..c01n 21/06, 00111 33/16 Field of Search ..23/23o B, 253 TP; 252/408 References Cited UNITED STATES PATENTS 3,453,180 7/1969 Fraser ..23/230 B OTHER PUBLICATIONS Chem. Abs. 67: 50965y (1967). Chem. Abs. 69: 93549y 1968). Chem. Abs. 69: l03698n 1968). Chem. Abs. 7i: I0133a(1969). Chem. Abs. 71: 278 172 (1969).

Primary Examiner-Morris O. Wolk Assistant Examiner-Sidney Marantz Attorney-Burgess, Dinklage & Sprung 57 ABSTRACT 7 Claims, 3 Drawing Figures REAGENT FOR DETERMINING BLOOD SUGAR The present invention is concerned with a reagent for the determination of blood sugar by the o-toluidine method, which reagent does not contain glacial acetic acid.

The determination of blood sugar with o-toluidine in glacial acetic acid is standard method in clinical laboratories. According to this method, the blood sample, after deproteinization, is mixed with about the tenfold amount of a reagent solution which contains o-toluidine and thiourea dissolved in glacial acetic acid. The mixture is heated, a green colored material being formed which is measured in a photometer at 630 nm.

This known method suffers from two important disadvantages which present considerable problems, especially in large laboratories in which routine analyses are carried out. On the one hand, the sensitivity is comparatively low, i.e., the possibility of error in the lower region of sensitivity is rather high. On the other hand, the use of glacial acetic acid as the the aldose-specific color reaction of o-toluidine, whereas, for

' example, isophthalic acid and terephthalic acid are useless for weight, based on total weight of composition.

reaction medium gives rise to a strong and very unpleasant smell, not only when pipetting the reagents but also when heating the samples in a boiling waterbath, as well as when cleaning the glass reaction vessels used. Furthermore, the corrosion of the photometer by the glacial acetic acid vapors is increased considerably.

Attempts have, therefore, already been made to overcome these disadvantages by the use of another solvent and reaction medium. Thus, it has already been proposed to use semi-con centrated acetic acid. However, this does not result in the disadvantages being overcome.

it has been proposed by A. Hartel et al (2. klin. Chem. u. klin, Biochem., 7, 14/1969) to replace the glacial acetic acid with a mixture of glycollic acid and malic acid, water, methanol and ethylene glycol monomethyl ether. A reagent of this type is also commercially available.

In the case of another commercially available reagent, the glacial acetic acid is' replaced with organic esters and salicylic acid.

The two above-mentioned glacial acetic acid-free reagents overcome the problem of malodor and also somewhat improve the sensitivity of the test. This sensitivity is, in the case of the usual normal values for the blood sugar content in whole blood of 60 100 mg. percent, below the value ofE 0.100 at the measurement wavelength of 578 nm usually employed.

However, in the case of very low blood sugar values, such as occur in the cases of hypoglycaemia, the extinction differences are of the order of the blank. Therefore, there is a need for the provision of a reagent which still further increases the sensitivity of the method.

A further disadvantage of the two above-mentioned known reagents is the instability of the solvent mixture which is due to the content of readily volatile components. The increased evaporation rate is of significance because the reagent must be heated for 8 minutes in a boiling waterbath for the development of the coloration. In the case of the known salicylic acidcontaining reagent, even after standing for about 1 hour in the air, the dissolved substances start to crystallize out.

Finally, another disadvantage is that the substances used instead of glacial acetic acid are considerably more expensive and thus the economic competitiveness of such reagents is impaired.

It is, therefore, an object of the present invention to provide a new reagent for the determination of blood sugar which avoids the above-mentioned disadvantages of the known reagents and is dependable, very sensitive and economical. v

The reagent according to the present invention for the determination of blood sugar contains o-toluidine, thiourea, an ethylene glycol mono-lower alkyl ether, and an acid and is characterized in that it contains phthalic acid as the acid and dimethyl formamide as a solubilizing agent.

From A. Haertel and H. Lang (Arztl. Lab., 15, 60/1966), it was known that non-hydroxylated dicarboxylic acids could not replace the glacial acetic acid because they prevented the formation of the desired colored material. It is, therefore, most surprising that phthalic acid is an outstanding catalyst for An especially preferred composition consists of 0.075 0.15 percent by weight thiourea, 20 25 percent by weight phthalic acid, 35 55 percent by weight dimethyl formamide, 20 40percent by weight ethylene glycol mono-lower alkyl ether and 7.5 10 percent by weight o-toluidine, based on total weight of composition.

Within the scope of the present invention, the term "lower alkly is to be understood to mean an alkyl radical containing up to six carbon atoms.

The reagent according to the present invention can contain up to about 5 percent water, without its usefulness being thereby impaired.

The reagent according to the present invention does not result in any unpleasant smell nor is there any danger of a loss of solvent when heating in order to bring about formation of the colored material. The reagent is colorless to pale yellow in color and the viscosity is low so that there is no impairment of the pipetting due to air bubbles or after-runnings. The afterrunnings in the case of a normal pipetting amount to 5 l percent, i.e., in the case of 2.0 ml. of reagent, are 0.02 ml. The reagent is also storage stable although, in the case of comparatively long periods of storage at an elevated temperature (33 C. an intensification of the yellow color can occur. However, this influences neither the measurement sensitivity to any considerable extent nor the stability of the color formed.

An especial advantage of the reagent according to the present invention is its outstanding sensitivity, even in the case of low glucose contents. Thus, even in the case of the range of 20 400 mg. percent (and even up to l g. percent) glucose content, there is obtained a very good linear proportionality between the extinction values at 578 nm and the glucose concentration. in this regard, reference is made to the accompanying drawings in which:

FIG. 1 is a plot extinction values against glucose concentration;

FIG. 2 is a plot of color intensity of an incubated test sample TABLE 1 Comparison of the Sensitivity of Various Blood Sugar Determination Methods Sensitivity-200 mg% glucose Sensitivity sra m in referred Reagent blank sample E to (i) (I) o-toluidine method with glacial acetic acid (2) o-toluidine 0.080 0.285 0.205 175.5% method without glacial acetic acid but with glycollic acid (3) o-toluidine 0.054 0.326 0.272 232% method without glacial acetic acid but with salicylic acid (4) reagent 0.049 0.382 0.333 285% mixture according to the invention of otoluidine and phthalic acid ratio of(4):(2)= 1.62: [.0

The superior sensitivity of the reagent according to the present invention, which can be seen from the last column of the above Table l, is of great practical importance since it is hereby possible, even in the cases of hypoglycaemia, as well as in the cases in which only very little blood is available, i.e., in the case of blood sugar measurement values of 30 50 mg. percent, to obtain extinctions of the order of 0.050 to 0.082 at 578 nm, measured against a blank, so that errors of measurement in the reading off of the photometer are very considerably reduced.

A further advantage of the reagent according to the present invention lies in the fact that in the region of the especially preferred composition, it represents a so-called optimum composition. This means that all individual components of the mixture are present in the concentration in which the sensitivity, the period of incubation of the test and the stability of the resultant color have their maxima and a slight alteration of the conditions does not cause any significant differences in the course of the test or in the measurement operation. The working errors are, therefore, in the case of this composition, extremely low.

The color which arises in the case of the o-toluidine reaction is, in principle, unstable. It is assumed that an unknown secondary reaction follows by means of which the extinction at 640 nm, the maximum, and at the measurement wavelength of 578 nm, decreases in the course of time. This instability of the color is reduced in the case of the reagent according to the had at ambient temperature at the end of the incubation. The

glycollic acid reagent was used as comparison reagent. There can clearly be appreciated the superior stability of the reagent according to the present invention. This improvement represents an important advantage when a large series of tests are to be measured one after the other.

A further advantage of the reagent according to the present invention lies in the fact that the stability is independent of the glucose concentration in the sample. The possibilities of error of the method are hereby minimized.

A further advantage of the reagent according to the present invention is its cheapness. Thus, the cost of phthalic acid is only about one-ninth of the cost of glycollic acid.

The following Examples are given for the purpose of illustrating the present invention:

Example 1 ml. ethylene glycol monoethyl ether were then added thereto and finally 18.0 ml. o-toluidine was stirred in.

For the purpose of deproteinization, 0.1 ml. of blood was pipetted into 1.0 ml. 3 percent trichloroacetic acid, mixed and, after standing for a few minutes, centrifuged.

From the supernatant, there was taken 0.2 ml. and this was mixed with 2.0 ml. of the above-described reagent according to the present invention. The mixture of supernatant and reagent was heated for 8 minutes on a boiling waterbath. After cooling in cold water, the resultant green colored material was measured in a photometer at 578 nm against a blank (trichloroacetic acid and reagent). A glucose standard mg. glucose/I00 ml. 0.2 percent benzoic acid solution) was treated in the same manner. The blood sugar content was calculated from the following equation:

sample X The determination was repeated with a series of blood samples of differing glucose content. The results obtained are set out in FIG. 1 of the accompanying drawings. They show the outstanding linear proportionality of the results which are obtained with the reagent according to the present invention.

In the above-described manner, the standard deviation of the determined blood sugar values from one another was ascertained by means of 10 determinations on the same serum. The standard deviation, which serves for the assessment of the distribution of the individual values around the arithmetic mean, was calculated from the following equation:

In the present case, s i: 1.25 mg. percent. As arithmetic mean value (Y) in the case of the 10 determinations, there was found 163.3 mg. percent glucose. The exactitude which can be achieved with the reagent according to the present invention can also be expressed by the following equation:

Y: 1 s= 1.63.31- 1.25 mg. percent The variation coefiicient VC), which is an expression of the standard deviation in percent of the mean value, amounted to i 0.76 percent, calculated from the following equation:

sXlOO Example 2 The o-toluidine method, with the use of the reagent according to. the present invention, was compared with the known enzymatic, highly specific blood sugar determination method, using the system hexokinase/intermediate enzyme. In this case, 25 different whole blood samples were tested in the manner described in Example 1. The same number of blood samples were determined enzymatically with hexokinase/intermediate enzyme. The blood sugar values obtained by both methods were compared. The results obtained are shown in FIG. 3 of the accompanying drawings. The good agreement of the values which were obtained by the two methods was obvious. The distribution of the comparable individual values was, on the average, 1 2.0 percent.

What is claimed is:

1. Areagent composition for determination of blood sugar which composition comprises o-toluidine, thiourea, an ethylene glycol mono-lower alkyl ether, phthalic acid, and dimethyl formamide as a solubilizing agent.

2. A reagent composition as claimed in claim 1 in which water is contained in an amount of up to 5 percent by volume.

3. Method for the determination of blood sugar which comprises mixing a blood sample with a reagent composition as claimed in claim 1 and measuring the resulting mixture photometrically'as an indication of the'blood sugar content.

4. A reagent composition as claimed in claim 1 which comprises 0.05 2.5 percent by weight thiourea, 5 33 percent by weight phthalic acid, 25 65 percent by weight dimethyl formamide, l0 50 percent by weight ethylene glycol monolower alkyl ether and 2.5 percent by weight o-toluidine, based on total weight of composition.

5. A reagent composition as claimed in claim 4 which comprises 0.075 0.15 percent by weight thiourea, percent by weight phthalic acid, 35 55 percent by weight dimethyl-formamide, 2O 40 percent by weight ethylene glycol mono-lower alkyl ether and 7.5 10 percent by weight o-toluidine, based on total weight of composition.

6. A reagent composition as claimed in claim 4 wherein the total volume of dimethyl formamide and of alkylene glycol mono-lower alkyl ether does not exceed parts by volume.

7 Method for the determination of blood sugar which comprises mixing a blood sample with a reagent composition as claimed in claim 4 and measuring the resulting mixture photometrically as an indication of the blood sugar content.

* Il l

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3453180 *Aug 2, 1965Jul 1, 1969Miles LabTest article
Non-Patent Citations
Reference
1 *Chem. Abs. 67: 50965y (1967).
2 *Chem. Abs. 69: 103698n (1968).
3 *Chem. Abs. 69: 93549y (1968).
4 *Chem. Abs. 71: 10133a (1969).
5 *Chem. Abs. 71: 27817z (1969).
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3853469 *Aug 30, 1972Dec 10, 1974Medico Electronic IncReagent and method for phosphorus determination
US3853473 *Aug 30, 1972Dec 10, 1974Medico Electronic IncReagent and method for urea determination
US4818702 *Mar 31, 1988Apr 4, 1989Litmus Concepts, Inc.Fecal occult blood test reagent
US5426032 *Nov 5, 1993Jun 20, 1995Lifescan, Inc.No-wipe whole blood glucose test strip
US5563042 *Mar 21, 1995Oct 8, 1996Lifescan, Inc.Whole blood glucose test strip
US5843692 *Sep 30, 1997Dec 1, 1998Lifescan, Inc.Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US6268162May 28, 1999Jul 31, 2001Lifescan, Inc.Reflectance measurement of analyte concentration with automatic initiation of timing
US6458326Nov 24, 1999Oct 1, 2002Home Diagnostics, Inc.Protective test strip platform
US6525330Feb 28, 2001Feb 25, 2003Home Diagnostics, Inc.Method of strip insertion detection
US6541266Feb 28, 2001Apr 1, 2003Home Diagnostics, Inc.Method for determining concentration of an analyte in a test strip
US6562625Feb 28, 2001May 13, 2003Home Diagnostics, Inc.Distinguishing test types through spectral analysis
US6821483Jun 24, 2002Nov 23, 2004Lifescan, Inc.Reagents test strip with alignment notch
US6858401Sep 23, 2002Feb 22, 2005Lifescan, Inc.Minimum procedure system for the determination of analytes
US6881550Jun 24, 2002Apr 19, 2005Roger PhillipsMethod for the determination of glucose employing an apparatus emplaced matrix
US6887426Jun 24, 2002May 3, 2005Roger PhillipsReagents test strip adapted for receiving an unmeasured sample while in use in an apparatus
US6979571Aug 1, 2002Dec 27, 2005Home Diagnostics, Inc.Method of using a protective test strip platform for optical meter apparatus
US7390665Mar 4, 2003Jun 24, 2008Gilmour Steven BDistinguishing test types through spectral analysis
WO1986003585A1 *Dec 10, 1985Jun 19, 1986Paul J LawrenceFecal occult blood test reagents and methods
Classifications
U.S. Classification436/95
International ClassificationC12Q1/54, G01N33/66
Cooperative ClassificationG01N33/66
European ClassificationG01N33/66